Literature DB >> 7211579

Total serum copper and ceruloplasmin levels following administration of copper aspirinate to rats and guinea-pigs.

D H Brown, J Dunlop, W E Smith, J Teape, A J Lewis.   

Abstract

Total serum copper and ceruloplasmin oxidase activities have been measured over a 24-h period in rats and guinea-pigs treated with 100 mg/kg body weight of copper (II) aspirinate. In the rat, administration s.c. produced higher total serum copper levels than oral administration at all time intervals studied, whereas in the guinea-pig, oral administration produced the higher level after 1 h and s.c. administration the higher level after 5 h. In both species, the rate of elimination of the additional copper was faster following oral administration. Ceruloplasmin oxidase activity appeared to be inhibited in certain cases but rose in all cases except for orally treated rats after 24 h. The initial rise in serum copper was due mainly to copper present on albumin. The increased albumin copper was detected directly by electrophoresis of serum samples and subsequent determination of the copper level in the portions of the strip which contained proteins. After s.c. administration to the rat, the amount of ultrafilterable copper was raised by a detectable amount. 7 h after s.c. or oral administration of copper aspirinate, the thiol concentration of the serum was reduced in both rats and guinea-pigs. The relationship of these levels to the anti-inflammatory action of copper (II) aspirinate in rats and guinea-pigs is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7211579     DOI: 10.1007/bf01968048

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  Concerning the merits of copper aspirin as a potential anti-inflammatory drug.

Authors:  K D Rainsford; M W Whitehouse
Journal:  J Pharm Pharmacol       Date:  1976-01       Impact factor: 3.765

2.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Copper chelates as possible active forms of the antiarthritic agents.

Authors:  J R Sorenson
Journal:  J Med Chem       Date:  1976-01       Impact factor: 7.446

4.  An evaluation of the use of electrophoresis and carbon furnace atomic absorption spectrometry to determine the copper level in separated serum protein fractions.

Authors:  J Teape; H Kamel; D H Brown; J M Ottaway; W E Smith
Journal:  Clin Chim Acta       Date:  1979-05-16       Impact factor: 3.786

5.  Microvascular lesions as a target of anti-inflammatory and certain other drugs.

Authors:  I L Bonta
Journal:  Acta Physiol Pharmacol Neerl       Date:  1969-06

6.  Determination of copper in plasma ultrafiltrate by atomic-absorption spectrometry using carbon furnace atomisation.

Authors:  H Kamel; J Teape; D H Brown; J M Ottaway; W E Smith
Journal:  Analyst       Date:  1978-09       Impact factor: 4.616

7.  A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig.

Authors:  A J Lewis
Journal:  Agents Actions       Date:  1978-04

8.  Copper distribution and reactivity in serum following administration of cuprous oxide to rats and guinea pigs.

Authors:  D H Brown; J Dunlop; W E Smith; J Teape
Journal:  Agents Actions       Date:  1979-12

9.  Antiinflammatory effects of some copper complexes.

Authors:  D H Brown; W E Smith; J W Teape; A J Lewis
Journal:  J Med Chem       Date:  1980-07       Impact factor: 7.446

  9 in total
  1 in total

1.  Human skin penetration of a copper tripeptide in vitro as a function of skin layer.

Authors:  Jurij J Hostynek; Frank Dreher; Howard I Maibach
Journal:  Inflamm Res       Date:  2010-08-20       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.